Purifying Selection in Human Immunodeficiency Virus-1

Adolescents Children HIV-1 pol gene Immunovirological dissociation Nonsynonymous mutations Purifying selection Synonymous mutations Virological failure

Journal

Journal of clinical medicine research
ISSN: 1918-3003
Titre abrégé: J Clin Med Res
Pays: Canada
ID NLM: 101538301

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 07 04 2020
accepted: 23 04 2020
entrez: 27 6 2020
pubmed: 27 6 2020
medline: 27 6 2020
Statut: ppublish

Résumé

Biological monitoring of antiretroviral treatment (ART) in human immunodeficiency virus (HIV)-infected pediatric population remains challenging. The aim of the present study was to assess the long-term HIV-1 genetic diversity in HIV-1 diversity in The immunological responses to ART basically corresponded to: 1) Full therapeutic failure with immunological (I Children and adolescents in immunovirological therapeutic failure harbor positive selection of HIV-1 strains favoring diversifying in

Sections du résumé

BACKGROUND BACKGROUND
Biological monitoring of antiretroviral treatment (ART) in human immunodeficiency virus (HIV)-infected pediatric population remains challenging. The aim of the present study was to assess the long-term HIV-1 genetic diversity in
METHODS METHODS
HIV-1 diversity in
RESULTS RESULTS
The immunological responses to ART basically corresponded to: 1) Full therapeutic failure with immunological (I
CONCLUSIONS CONCLUSIONS
Children and adolescents in immunovirological therapeutic failure harbor positive selection of HIV-1 strains favoring diversifying in

Identifiants

pubmed: 32587653
doi: 10.14740/jocmr4157
pmc: PMC7295550
doi:

Types de publication

Journal Article

Langues

eng

Pagination

369-376

Informations de copyright

Copyright 2020, Mboumba Bouassa et al.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest regarding the publication of this paper.

Références

J Antimicrob Chemother. 2010 Jan;65(1):118-24
pubmed: 19933171
Virus Res. 2008 Jun;134(1-2):104-23
pubmed: 18289713
AIDS. 2003 Mar 28;17(5):663-71
pubmed: 12646788
Mol Biol Evol. 1999 May;16(5):711-4
pubmed: 10335663
Nature. 1995 Jul 13;376(6536):125
pubmed: 7603560
J Infect Dis. 2001 May 15;183(10):1445-54
pubmed: 11329124
J Infect Dis. 2003 Apr 1;187(7):1027-37
pubmed: 12660916
AIDS Res Hum Retroviruses. 2012 Jan;28(1):87-94
pubmed: 21599597
J Mol Evol. 1980 Dec;16(2):111-20
pubmed: 7463489
Expert Rev Anti Infect Ther. 2015;13(10):1213-23
pubmed: 26204960
Clin Infect Dis. 2005 Sep 1;41(5):729-37
pubmed: 16080097
AIDS Res Hum Retroviruses. 2013 Feb;29(2):242-9
pubmed: 22860571
Genetics. 2006 Nov;174(3):1441-53
pubmed: 16951087
J Virol. 1998 Sep;72(9):7632-7
pubmed: 9696866
J Int AIDS Soc. 2016 Apr 27;19(1):20683
pubmed: 27125320
PLoS Pathog. 2010 Nov 24;6(11):e1001213
pubmed: 21124822
PLoS One. 2016 Jun 10;11(6):e0156099
pubmed: 27284683
J Mol Evol. 1980 Sep;16(1):23-36
pubmed: 6449605
Sci Transl Med. 2016 Sep 28;8(358):358ra125
pubmed: 27683550
Pediatr Infect Dis J. 2011 Jan;30(1):52-6
pubmed: 20631647
J Gen Virol. 2001 Oct;82(Pt 10):2495-2508
pubmed: 11562542
PLoS One. 2010 May 24;5(5):e10788
pubmed: 20520721
New Microbiol. 2004 Apr;27(2 Suppl 1):45-50
pubmed: 15646064
Mol Biol Evol. 2011 Oct;28(10):2731-9
pubmed: 21546353
J Infect Dis. 2002 Aug 1;186(3):312-20
pubmed: 12134227
J Virol. 2000 Sep;74(18):8524-31
pubmed: 10954553
Mol Biol Evol. 1986 Sep;3(5):418-26
pubmed: 3444411
Mol Biol Evol. 1995 Sep;12(5):803-13
pubmed: 7476126
J Infect Dis. 2000 Apr;181(4):1479-82
pubmed: 10762580
AIDS. 2002 Jan 25;16(2):201-7
pubmed: 11807304
J Infect Dis. 2002 Feb 1;185(3):315-23
pubmed: 11807713
Medicine (Baltimore). 2017 Mar;96(10):e6282
pubmed: 28272247
Genetics. 2000 May;155(1):431-49
pubmed: 10790415
AIDS. 2009 Jan 28;23(3):335-42
pubmed: 19114870
PLoS Comput Biol. 2007 Feb 16;3(2):e29
pubmed: 17305421
Nature. 1977 May 19;267(5608):275-6
pubmed: 865622
AIDS. 2002 Apr 12;16(6):839-49
pubmed: 11919485
AIDS Res Hum Retroviruses. 2004 Dec;20(12):1306-13
pubmed: 15650423
Annu Rev Microbiol. 1997;51:151-78
pubmed: 9343347
PLoS One. 2013;8(3):e58526
pubmed: 23505529
J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):566-9
pubmed: 19202461
J Virol. 1998 Apr;72(4):3300-6
pubmed: 9525657

Auteurs

Ralph-Sydney Mboumba Bouassa (RS)

Laboratoire de Virologie, Hopital Europeen Georges Pompidou, Assistance Publique-Hopitaux de Paris (AP-HP) and Universite de Paris, Paris Sorbonne Cite, Paris, France.
Ecole Doctorale Regionale en Infectiologie Tropicale, Franceville, Gabon.

Helene Pere (H)

Laboratoire de Virologie, Hopital Europeen Georges Pompidou, Assistance Publique-Hopitaux de Paris (AP-HP) and Universite de Paris, Paris Sorbonne Cite, Paris, France.
Universite de Paris, Paris Sorbonne Cite, Paris, France.

Christian Diamant Mossoro-Kpinde (CD)

Faculte des Sciences de la Sante, Universite de Bangui, Bangui, Central African Republic.
Laboratoire National de Biologie Clinique et de Sante Publique, Bangui, Central African Republic.

Pierre Roques (P)

Commissariat a l'Energie Atomique (CEA)-Universite Paris-Saclay; INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases (IMVA), IDMIT Department, Institut de Biologie Francois-Jacob (IBJF), Fontenay-aux-Roses, France.

Jean Chrysostome Gody (JC)

Faculte des Sciences de la Sante, Universite de Bangui, Bangui, Central African Republic.
Complexe Pediatrique, Bangui, Central African Republic.

Sandrine Moussa (S)

Institut Pasteur de Bangui, Bangui, Central African Republic.

David Veyer (D)

Laboratoire de Virologie, Hopital Europeen Georges Pompidou, Assistance Publique-Hopitaux de Paris (AP-HP) and Universite de Paris, Paris Sorbonne Cite, Paris, France.

Gerard Gresenguet (G)

Faculte des Sciences de la Sante, Universite de Bangui, Bangui, Central African Republic.
Unite de Recherches et d'Intervention sur les Maladies Sexuellement Transmissibles et le SIDA, Departement de Sante Publique, Faculte des Sciences de la Sante de Bangui, Central African Republic.

Charlotte Charpentier (C)

IAME, UMR 1137, INSERM, Universite Paris Diderot, Sorbonne Paris Cite, AP-HP, Laboratoire de Virologie, Hopital Bichat, AP-HP, Paris, France.

Mohammad-Ali Jenabian (MA)

Departement des Sciences Biologiques et Centre de Recherche BioMed, Universite du Quebec a Montreal (UQAM), Montreal, QC, Canada.

Joel Fleury Djoba Siawaya (JF)

Ecole Doctorale Regionale en Infectiologie Tropicale, Franceville, Gabon.
Laboratory Medicine, Mother and Child University Hospital Jeanne Ebori, Libreville, Gabon.

Laurent Belec (L)

Laboratoire de Virologie, Hopital Europeen Georges Pompidou, Assistance Publique-Hopitaux de Paris (AP-HP) and Universite de Paris, Paris Sorbonne Cite, Paris, France.
Ecole Doctorale Regionale en Infectiologie Tropicale, Franceville, Gabon.
Universite de Paris, Paris Sorbonne Cite, Paris, France.

Classifications MeSH